Long-term safety of fixed-dose combinations: azilsartan medoxomil/chlorthalidone (AZL-M/CLD) vs olmesartan medoxomil/hydrochlorothiazide (OLM/HCTZ) in hypertensive subjects with stage 3 chronic kidney disease
Journal of the American Society of Hypertension（2014）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要